December 10, 2013 (Chicago, IL)
At its Annual Dinner event, the Illinois Venture Capital Association (IVCA) last night honored Actient Pharmaceuticals as its 2013 Portfolio Company of the Year. The award recognizes an Illinois company that was backed by private equity, experienced substantial revenue growth, and had a realized liquidity event. Former Actient CEO, Ed Fiorentino, received the award on behalf of the Lake Forest, Illinois, company.
GTCR Managing Director, Dean Mihas, presented the IVCA award to Mr. Fiorentino. “Our partnership with pharmaceutical industry veteran Ed Fiorentino and the formation of Actient was emblematic of The Leaders Strategy™ – to partner with exceptional management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth,” said Mr. Mihas. “It would be an understatement to say that Ed made a lot of good things happen in three short years. But what was truly impressive was how he crafted a vision and strategy within the pharma industry, and then worked relentlessly to build and lead an organization to execute and achieve success.”
Actient was sold last April by GTCR to Auxilium Pharmaceuticals, Inc. Mr. Fiorentino left the company at that time and recently entered into his second partnership with GTCR to form Crealta Pharmaceuticals, Inc. The new company, headquartered in Lake Forest, Illinois, will focus on acquiring specialty pharmaceutical companies and products as part of a strategy to build a leading company in the industry.